Chesley Taft & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $245K | Hold |
|
|||||
|
2025
Q2 | $228K | Sell |
|
|||||
|
2025
Q1 | $308K | Hold |
|
|||||
|
2024
Q4 | $345K | Hold |
|
|||||
|
2024
Q3 | $510K | Hold |
|
|||||
|
2024
Q2 | $510K | Hold |
|
|||||
|
2024
Q1 | $467K | Hold |
|
|||||
|
2023
Q4 | $426K | Hold |
|
|||||
|
2023
Q3 | $399K | Hold |
|
|||||
|
2023
Q2 | $348K | Hold |
|
|||||
|
2023
Q1 | $399K | Hold |
|
|||||
|
2022
Q4 | $350K | Hold |
|
|||||
|
2022
Q3 | $334K | Sell |
|
|||||
|
2022
Q2 | $626K | Buy |
|
|||||
|
2022
Q1 | $737K | Hold |
|
|||||
|
2021
Q4 | $650K | Buy |
|
|||||
|
2021
Q3 | $559K | Hold |
|
|||||
|
2021
Q2 | $516K | Sell |
|
|||||
|
2021
Q1 | $474K | Sell |
|
|||||
|
2020
Q4 | $567K | Hold |
|
|||||
|
2020
Q3 | $657K | Sell |
|
|||||
|
2020
Q2 | $919K | Hold |
|
|||||
|
2020
Q1 | $719K | Buy |
|
|||||
|
2019
Q4 | $534K | Sell |
|
|||||
|
2019
Q3 | $404K | Buy |
|
|||||
|
2019
Q2 | $400K | Sell |
|
|||||
|
2019
Q1 | $1.57M | Sell |
|
|||||
|
2018
Q4 | $1.44M | Sell |
|
|||||
|
2018
Q3 | $1.78M | Hold |
|
|||||
|
2018
Q2 | $1.52M | Sell |
|
|||||
|
2018
Q1 | $1.56M | Sell |
|
|||||
|
2017
Q4 | $1.73M | Hold |
|
|||||
|
2017
Q3 | $2.06M | Sell |
|
|||||
|
2017
Q2 | $2.27M | Hold |
|
|||||
|
2017
Q1 | $1.79M | Hold |
|
|||||
|
2016
Q4 | $1.7M | Sell |
|
|||||
|
2016
Q3 | $1.92M | Sell |
|
|||||
|
2016
Q2 | $1.75M | Hold |
|
|||||
|
2016
Q1 | $1.8M | Sell |
|
|||||
|
2015
Q4 | $5.29M | Sell |
|
|||||
|
2015
Q3 | $5.08M | Sell |
|
|||||
|
2015
Q2 | $5.88M | Sell |
|
|||||
|
2015
Q1 | $5.83M | Hold |
|
|||||
|
2014
Q4 | $5.3M | Hold |
|
|||||
|
2014
Q3 | $4.66M | Sell |
|
|||||
|
2014
Q2 | $3.76M | Sell |
|
|||||
|
2014
Q1 | $4.01M | Sell |
|
|||||
|
2013
Q4 | $3.69M | Sell |
|
|||||
|
2013
Q3 | $4.24M | Sell |
|
|||||
|
2013
Q2 | $5.21M | Buy |
|